NCT00992732 · Interventional trial
Study of HQK-1004 and Valganciclovir to Treat Epstein-Barr Virus (EBV) - Positive Lymphoid Malignancies or Lymphoproliferative Disorders
Overall registry status Terminated
Phase 2
Conditions Lymphoid Malignancies, Lymphoproliferative Disorders
Delaware Valley sites
- Abramson Cancer Center of the University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory